AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NeuroPace Inc Director's Dealing 2022

Jun 21, 2022

33194_dirs_2022-06-21_bbfc4e2d-69a6-481d-b01c-0707a6c5373b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2022-06-13

Reporting Person: Garfield Greg Shaw (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-13	Stock Option (Right to Buy)	$6.30	A	18253	Acquired	2032-06-12	Common Stock (18253)	Direct

Footnotes

F1: The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable.